Immune globulin and hyaluronidase Subcutaneous and Kisqali (200 MG Dose)
Determining the interaction of Immune globulin and hyaluronidase Subcutaneous and Kisqali (200 MG Dose) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hyaluronidase / immune globulin
Brand name: Hyqvia
Synonyms: Hyaluronidase and immune globulin
Generic Name: ribociclib
Brand name: Kisqali
Synonyms: Kisqali
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Immune globulin and hyaluronidase Subcutaneous-Kisqali (400 MG Dose)
- Immune globulin and hyaluronidase Subcutaneous-Kisqali (600 MG Dose)
- Immune globulin and hyaluronidase Subcutaneous-Kisqali Femara Co-Pack
- Immune globulin and hyaluronidase Subcutaneous-Kisqali Femara Co-Pack 200 mg-2.5 mg Dose
- Immune globulin and hyaluronidase Subcutaneous-Kisqali Femara Co-Pack 400 mg-2.5 mg Dose
- Immune globulin and hyaluronidase Subcutaneous-Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
- Kisqali (200 MG Dose)-Immune Globulin Injection (IM)
- Kisqali (200 MG Dose)-Immune Globulin Injection (IV)
- Kisqali (200 MG Dose)-Immune Globulin Injection (Subcutaneous or IV)
- Kisqali (200 MG Dose)-Immune Globulin Injection (Subcutaneous)
- Kisqali (200 MG Dose)-Immune globulin intravenous and subcutaneous
- Kisqali (200 MG Dose)-Immune globulin subcutaneous